Sexuality and schizophrenia: a review

DL Kelly, RR Conley - Schizophrenia bulletin, 2004 - academic.oup.com
Sexual functioning has received little attention as an important aspect of patient care for
those suffering from severe mental disorders such as schizophrenia. Yet, it has been …

[图书][B] The use of psychological testing for treatment planning and outcomes assessment: Volume 3: Instruments for adults

ME Maruish - 2004 - taylorfrancis.com
Test-based psychological assessment has been significantly affected by the health care
revolution in the United States during the past two decades. Despite new limitations on …

Duloxetine in the treatment of depression: a double-blind placebo-controlled comparison with paroxetine

DJ Goldstein, Y Lu, MJ Detke, C Wiltse… - Journal of clinical …, 2004 - journals.lww.com
Objective: To evaluate duloxetine, a dual reuptake inhibitor of serotonin and norepinephrine,
on improvement of emotional and painful physical symptoms. Design: Randomized, double …

Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo-and paroxetine-controlled trial

MJ Detke, CG Wiltse, CH Mallinckrodt… - European …, 2004 - Elsevier
Background: Duloxetine is a balanced and potent dual reuptake inhibitor of serotonin (5-HT)
and norepinephrine (NE) that has previously been shown to be effective in the acute …

Just ask! Talking to patients about sexual function

S Kingsberg - Sexuality, Reproduction and Menopause, 2004 - Elsevier
There'sa simple way to overcome the obstacles to discussing sexual concerns with your
patients: Simply ask. This helpful review of female sexual dysfunction focuses on lack of …

A double‐blind placebo‐controlled trial of milnacipran in the treatment of fibromyalgia

O Vitton, M Gendreau, J Gendreau… - Human …, 2004 - Wiley Online Library
Fibromyalgia syndrome is a systemic disorder of widespread pain which is thought to result
from abnormal pain processing within the central nervous system. There are no currently …

Response acceleration with mirtazapine augmentation of citalopram in obsessive-compulsive disorder patients without comorbid depression: a pilot study

S Pallanti, L Quercioli, M Bruscoli - Journal of Clinical Psychiatry, 2004 - psychiatrist.com
Background: Therapeutic action of selective serotonin reuptake inhibitors (SSRIs) is delayed
from 8 to 12 weeks in patients with obsessivecompulsive disorder (OCD). Several different …

A double-blind placebo-controlled study of controlled release fluvoxamine for the treatment of generalized social anxiety disorder

HGM Westenberg, DJ Stein, H Yang, D Li… - Journal of clinical …, 2004 - journals.lww.com
This was a randomized double-blind placebo-controlled multicenter study to assess the
efficacy, safety, and tolerability of fluvoxamine in a controlled release (CR) formulation for …

Fluvoxamine-controlled release formulation for the treatment of generalized social anxiety disorder

J Davidson, J Yaryura-Tobias, R DuPont… - Journal of Clinical …, 2004 - journals.lww.com
Background: Generalized social anxiety disorder is a highly prevalent anxiety disorder with
deleterious effects on social and family relationships, as well as work performance. We …

[图书][B] Parkinson's disease

RF Pfeiffer, ZK Wszolek, M Ebadi - 2004 - taylorfrancis.com
Recent research is leading to an ever-increasing range of investigative approaches whose
aim is to achieve effective neuroprotective or neurorestorative treatment for individuals …